← Case Library

Clause 7.8

⚖ 20 PMCPA cases 🔒 Members see all 20 cases

PMCPA Cases — Clause 7.8

20 cases
📅 8 Mar 2026 · Roche Products

Novartis v Roche: Bondronat leavepiece—misleading indirect comparisons and renal safety messaging (AUTH/2199/1/09)

Clause 7.10 Clause 7.2 Clause 7.3 Clause 7.4 +2 more
📅 8 Mar 2026 · Roche Products

AUTH/2191/12/08: Roche misleading comparative and “cost-effective” claims in Bondronat hospital detail aid (Novartis complaint)

Clause 7.10 Clause 7.2 Clause 7.3 Clause 7.4 +2 more
📅 8 Mar 2026 · Merz Pharma UK

AUTH/2177/10/08: Allergan v Merz Pharma (Xeomin leavepiece) – misleading implied clinical advantage from “free from complexing proteins”

Clause 7.10 Clause 7.2 Clause 7.8
🔒

See all 20 cases for Clause 7.8

Case Library members get full access to every PMCPA ruling, searchable by clause, company, outcome, and sanction.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

Already a member? Sign in

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free